METRNL and Insulin resistance: Previous study reported that adipocyte Metrnl controls insulin sensitivity through the peroxisome proliferator-activated receptor gamma (PPARγ) pathway and suggested that adipocyte Metrnl is an inherent insulin sensitizer and may be a therapeutic target for insulin resistance [11].